2-Site Safety Study of Besivance Versus Vigamox Prophylactically in Routine Cataract Surgery
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate that Besivance is equal to Vigamox in safety and
tolerance when used prophylactically in subjects undergoing routine cataract surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Ophthalmology Consultants, Ltd.
Collaborators:
Bausch & Lomb Incorporated Ophthalmology Associates, St Louis